RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ihsan Salloum to Humans

This is a "connection" page, showing publications Ihsan Salloum has written about Humans.
Connection Strength

0.467
  1. Francis AN, Salloum IM. High-resolution mapping of alcohol-related brain connectivity in adults using 7T fMRI and multivoxel pattern classification. Psychiatry Res Neuroimaging. 2025 Sep; 352:112046.
    View in: PubMed
    Score: 0.043
  2. Ware OD, Cano MT, Dalal Safa M, Garza N, Martinez S, Salloum I. Availability of substance use disorder treatment in Spanish: Associations with state-level proportions of Spanish speakers and treatment facility characteristics in the United States. Am J Addict. 2024 07; 33(4):400-408.
    View in: PubMed
    Score: 0.038
  3. Sinha A, Shariq A, Said K, Sharma A, Jeffrey Newport D, Salloum IM. Medical Comorbidities in Bipolar Disorder. Curr Psychiatry Rep. 2018 05 07; 20(5):36.
    View in: PubMed
    Score: 0.026
  4. Cisse A, Giles C, Salloum IM. Yoga in the Yard. Psychiatr Serv. 2017 09 01; 68(9):980.
    View in: PubMed
    Score: 0.025
  5. Salloum IM, Brown ES. Management of comorbid bipolar disorder and substance use disorders. Am J Drug Alcohol Abuse. 2017 07; 43(4):366-376.
    View in: PubMed
    Score: 0.024
  6. Cornelius JR, Chung T, Douaihy AB, Kirisci L, Glance J, Kmiec J, FitzGerald D, Wesesky MA, Salloum I. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial. Psychiatry Res. 2016 Aug 30; 242:326-330.
    View in: PubMed
    Score: 0.023
  7. Garcia AN, Salloum IM. Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: A focused review. Am J Addict. 2015 Oct; 24(7):590-8.
    View in: PubMed
    Score: 0.022
  8. Johnson SL, Murray G, Fredrickson B, Youngstrom EA, Hinshaw S, Bass JM, Deckersbach T, Schooler J, Salloum I. Creativity and bipolar disorder: touched by fire or burning with questions? Clin Psychol Rev. 2012 Feb; 32(1):1-12.
    View in: PubMed
    Score: 0.016
  9. Cornelius JR, Douaihy A, Bukstein OG, Daley DC, Wood SD, Kelly TM, Salloum IM. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents. Addict Behav. 2011 Aug; 36(8):843-8.
    View in: PubMed
    Score: 0.016
  10. Mezzich JE, Snaedal J, van Weel C, Botbol M, Salloum I. Introduction to person-centred medicine: from concepts to practice. J Eval Clin Pract. 2011 Apr; 17(2):330-2.
    View in: PubMed
    Score: 0.015
  11. Salloum IM, Mezzich JE. Outlining the bases of person-centred integrative diagnosis. J Eval Clin Pract. 2011 Apr; 17(2):354-6.
    View in: PubMed
    Score: 0.015
  12. Mezzich JE, Salloum IM. Towards innovative international classification and diagnostic systems: ICD-11 and person-centered integrative diagnosis. Acta Psychiatr Scand. 2007 Jul; 116(1):1-5.
    View in: PubMed
    Score: 0.012
  13. Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord. 2006 Dec; 8(6):677-85.
    View in: PubMed
    Score: 0.012
  14. Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study. Addict Behav. 2007 Feb; 32(2):410-5.
    View in: PubMed
    Score: 0.011
  15. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 2: treatment issues. AIDS Read. 2005 Nov; 15(11):604-6, 611-3, 618.
    View in: PubMed
    Score: 0.011
  16. Douaihy AB, Stowell KR, Bui T, Daley D, Salloum I. HIV/AIDS and homelessness, Part 1: background and barriers to care. AIDS Read. 2005 Oct; 15(10):516-20, 527.
    View in: PubMed
    Score: 0.011
  17. Salloum IM, Cornelius JR, Douaihy A, Kirisci L, Daley DC, Kelly TM. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study. Addict Behav. 2005 Oct; 30(9):1702-8.
    View in: PubMed
    Score: 0.011
  18. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2005 Jan; 62(1):37-45.
    View in: PubMed
    Score: 0.010
  19. Cornelius JR, Clark DB, Bukstein OG, Salloum IM. Treatment of co-occurring alcohol, drug, and psychiatric disorders. Recent Dev Alcohol. 2005; 17:349-65.
    View in: PubMed
    Score: 0.010
  20. Salloum IM, Douaihy A, Ndimbie OK, Kirisci L. Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients. J Addict Dis. 2004; 23(2):71-81.
    View in: PubMed
    Score: 0.010
  21. Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Read. 2003 Aug; 13(8):375-82.
    View in: PubMed
    Score: 0.009
  22. Douaihy AB, Jou RJ, Gorske T, Salloum IM. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Read. 2003 Jul; 13(7):331-2, 339-41.
    View in: PubMed
    Score: 0.009
  23. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord. 2002 Dec; 4(6):418-21.
    View in: PubMed
    Score: 0.009
  24. Kwako LE, Patterson J, Salloum IM, Trim RS. Alcohol Use Disorder and Co-Occurring Mental Health Conditions. Alcohol Res. 2019; 40(1).
    View in: PubMed
    Score: 0.007
  25. Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, Rosenthal RN, Dunn KE, Strain EC, Ray L, Shoptaw S, Ait-Daoud Tiouririne N, Gunderson EW, Ransom J, Scott C, Leggio L, Caras S, Mason BJ, Litten RZ. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety. Alcohol Clin Exp Res. 2019 01; 43(1):158-169.
    View in: PubMed
    Score: 0.007
  26. Mar?n-Navarrete R, Medina-Mora ME, Horigian VE, Salloum IM, Villalobos-Gallegos L, Fern?ndez-Mondrag?n J. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use. J Dual Diagn. 2016 Jul-Dec; 12(3-4):261-270.
    View in: PubMed
    Score: 0.006
  27. Balon R, Guerra E, Meador-Woodruff JH, Oquendo MA, Salloum IM, Casiano DE, Nemeroff CB. Innovative approach to research training: research colloquium for junior investigators. Acad Psychiatry. 2011 Jan-Feb; 35(1):11-4.
    View in: PubMed
    Score: 0.004
  28. Mezzich JE, Salloum IM, Cloninger CR, Salvador-Carulla L, Kirmayer LJ, Banzato CE, Wallcraft J, Botbol M. Person-centred integrative diagnosis: conceptual bases and structural model. Can J Psychiatry. 2010 Nov; 55(11):701-8.
    View in: PubMed
    Score: 0.004
  29. Maremmani I, Pacini M, Lamanna F, Pani PP, Perugi G, Deltito J, Salloum IM, Akiskal H. Mood stabilizers in the treatment of substance use disorders. CNS Spectr. 2010 Feb; 15(2):95-109.
    View in: PubMed
    Score: 0.004
  30. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010 Mar; 167(3):289-97.
    View in: PubMed
    Score: 0.004
  31. Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, Urschel HC, Elkashef AM. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009 Sep 01; 104(1-2):133-9.
    View in: PubMed
    Score: 0.004
  32. Copeland LA, Zeber JE, Salloum IM, Pincus HA, Fine MJ, Kilbourne AM. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis. 2008 Jan; 196(1):16-21.
    View in: PubMed
    Score: 0.003
  33. Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. J Subst Abuse Treat. 2006 Jan; 30(1):73-7.
    View in: PubMed
    Score: 0.003
  34. Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown SA. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review. Addict Behav. 2005 Oct; 30(9):1824-33.
    View in: PubMed
    Score: 0.003
  35. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9.
    View in: PubMed
    Score: 0.003
  36. Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study. Addict Behav. 2005 May; 30(4):807-14.
    View in: PubMed
    Score: 0.003
  37. Kilbourne AM, Cornelius JR, Han X, Haas GL, Salloum I, Conigliaro J, Pincus HA. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry. 2005 Mar; 13(3):250-4.
    View in: PubMed
    Score: 0.003
  38. Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004 Oct; 6(5):368-73.
    View in: PubMed
    Score: 0.003
  39. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol. 2004 Aug; 24(4):421-8.
    View in: PubMed
    Score: 0.002
  40. Cornelius JR, Maisto SA, Martin CS, Bukstein OG, Salloum IM, Daley DC, Wood DS, Clark DB. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004 Jul; 29(5):1035-8.
    View in: PubMed
    Score: 0.002
  41. Cornelius JR, Clark DB, Salloum IM, Bukstein OG, Kelly TM. Interventions in suicidal alcoholics. Alcohol Clin Exp Res. 2004 May; 28(5 Suppl):89S-96S.
    View in: PubMed
    Score: 0.002
  42. Le Fauve CE, Litten RZ, Randall CL, Moak DH, Salloum IM, Green AI. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res. 2004 Feb; 28(2):302-12.
    View in: PubMed
    Score: 0.002
  43. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation. J Child Adolesc Psychopharmacol. 2004; 14(1):33-8.
    View in: PubMed
    Score: 0.002
  44. Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, Barber JP, Blaine J, Salloum I, Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry. 2003 Jul; 160(7):1320-5.
    View in: PubMed
    Score: 0.002
  45. Woody GE, Gallop R, Luborsky L, Blaine J, Frank A, Salloum IM, Gastfriend D, Crits-Christoph P. HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr. 2003 May 01; 33(1):82-7.
    View in: PubMed
    Score: 0.002
  46. Cornelius JR, Maisto SA, Pollock NK, Martin CS, Salloum IM, Lynch KG, Clark DB. Rapid relapse generally follows treatment for substance use disorders among adolescents. Addict Behav. 2003 Mar; 28(2):381-6.
    View in: PubMed
    Score: 0.002
  47. Cornelius JR, Bukstein O, Salloum I, Clark D. Alcohol and psychiatric comorbidity. Recent Dev Alcohol. 2003; 16:361-74.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support